Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC)

被引：0

作者：

Westeel, V. ^{[1
]}

Barlesi, F. ^{[2
]}

Foucher, P. ^{[3
]}

Lafitte, J-J. ^{[4
]}

Domas, J. ^{[5
]}

Girard, P. ^{[6
]}

Tredaniel, J. ^{[7
]}

Wislez, M. ^{[8
]}

Dumont, P. ^{[9
]}

Quoix, E. ^{[10
]}

Raffy, O. ^{[11
]}

Braun, D. ^{[12
]}

Derollez, M. ^{[13
]}

Goupil, F. ^{[14
]}

Hermann, J. ^{[15
]}

Devin, E. ^{[16
]}

Pichon, E. ^{[17
]}

Gury, J-P. ^{[18
]}

Morin, F. ^{[19
]}

Souquet, P-J. ^{[20
]}

机构：

[1] Hop Jean Minjoz, CHRU Besancon, Pneumol, Besancon, France

[2] Aix Marseille Univ, AP HM, Multidisciplinary Oncol & Therapeut Innovat, Marseille, France

[3] CHU Le Bocage Dijon, Pneumol, Dijon, France

[4] CHRU Lille, Hop Calmette, Pneumol, Lille, France

[5] Ctr Catalan Oncol Clin St Pierre, Pneumol, Perpignan, France

[6] Inst Mutualiste Montsouris, Pneumol, Paris, France

[7] Hop St Joseph, Pneumol, Paris, France

[8] Tenon Univ Hosp, AP HP, Pneumol, CancerEst, Paris, France

[9] Ctr Hosp, Pneumol, Chauny, France

[10] CHU Strasbourg, Serv Pneumol, Pole Pathol Thorac, NHC, Strasbourg, France

[11] Ctr Hosp, Pneumol, Chartres, France

[12] Cabinet, Pneumol, Briey, France

[13] Clin Val de Sambre, Pneumol, Maubeuge, France

[14] Ctr Hosp, Pneumol, Le Mans, France

[15] HPMetz Hop Robert Schuman, Pneumol, Metz, France

[16] CHI EureSeine Evreux, Pneumol, Evreux, France

[17] CHRU Bretonneau, Pneumol, Tours, France

[18] Ctr Hosp, Pneumol, Vesoul, France

[19] French Cooperat Thorac Intergrp, Clin Res Unit, Paris, France

[20] Ctr Hosp Lyon Sud, Pneumol, Pierre Benite, France

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1273O

引用

页数：1

共 50 条

[31] A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer
Kunitoh, H.
Sakurai, H.
Tsuboi, M.
Wakabayashi, M.
Okada, M.
Suzuki, K.
Ikeda, N.
Takahama, M.
Takenoyama, M.
Ohde, Y.
Yoshiya, K.
Matsumoto, I.
Yamashita, M.
Marutsuka, T.
Date, H.
Hasumi, T.
Yamashita, Y.
Okumura, N.
Watanabe, S.
Asamura, H.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S270 - S271
[32] Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer
Li, Xiongfei
Fan, Fanfan
Yang, Zijiang
Huang, Qingyuan
Fu, Fangqiu
Zhang, Yang
Chen, Haiquan
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 5729 - 5737
[33] The Role of MonoTotal in the Primary Diagnosis, Prognosis and Follow-up of Patients with Non-small Cell Lung Cancer (NSCLC)
Prazakova, Marketa
Vrzalova, Jindra
Maria Auge, Josep
Safranek, Jarmil
Topolcan, Ondrej
Fuchsova, Radka
Spisakova, Marketa
Svobodova, Sarka
Holubec, Lubos, Jr.
Pesta, Martin
ANTICANCER RESEARCH, 2011, 31 (09) : 3107 - 3112
[34] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
Antón, A
Díaz-Fernández, N
Larriba, JG
Vadell, C
Masutti, B
Montalar, J
Barneto, I
Artal, A
Rosell, R
LUNG CANCER, 1998, 22 (02) : 139 - 148
[35] Patient outcome following adjuvant chemotherapy (CT) in completely resected, stage I-IIIB, non-small cell lung cancer (NSCLC)
Dediu, M.
Horvat, T.
Anghel, R.
Tarlea, A.
Alexandru, A.
Median, D.
Nistor, C.
Ciuche, A.
Savu, C.
Iorga, P.
PROCEEDINGS OF THE 10TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2006, : 31 - +
[36] Patient outcome following adjuvant chemotherapy (CT) in completely resected, stage I-IIIB, non-small cell lung cancer (NSCLC)
Dediu, M.
Horvat, T.
Anghel, R.
Tarlea, A.
Alexandru, A.
Median, D.
Nistor, C.
Savu, C.
Ciuche, A.
Iorga, P.
LUNG CANCER, 2006, 52 : S20 - S21
[37] Update of a phase III trial of adjuvant vinorelbine plus cisplatin (NP) versus NP plus endostar (NPE) in patients with completely resected stage IB-IIIA non-small cell lung cancer (NSCLC)
Jie, He
Han, Baohui
Liu, Yongyu
Wu, Shi Xiu
Kuang, Yukang
Shen, Yi
Chen, Chun
Wang, Qun
Li, Qiang
Ma Haitao
Xu, Shaofa
Xu, Shidong
Wang, Ping
Mao, Weimin
Pang, Zuoliang
Hou, Shengcai
Yang, Yue
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[38] A pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small cell lung cancer (NSCLC)
Fruh, M.
Tribodet, H.
Pignon, J.
Winton, T.
Le Chevalier, T.
Scagliotti, G. V.
Douillard, J. Y.
Seymour, L.
Spiro, S. G.
Shepherd, F. A.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[39] A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.
Calvo, Virginia
Domine, Manuel
Sullivan, Ivana
Gonzalez-Larriba, Jose-Luis
Ortega, Ana Laura
Bernabe, Reyes
Sala, Maria Angeles
Campos, Begona
De Castro, Javier
Martin-Martorell, Paloma
Bosch-Barrera, Joaquim
Mielgo, Xabier
Vila, Laia
Casal, Joaquin
Ros, Silver
Aguillo, Maite Martinez
Padilla, Airam
Sandiego, Sergio
Machado, Jonathan Aires
Provencio-Pulla, Mariano
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[40] Follow-Up on Results of a Multidisciplinary Team in the Management of Non-Small Cell Lung Cancer in a Developing Country
Corrales-Rodriguez, Luis
Juarez, Melissa
Ramos-Esquivel, Allan
Caballero, Manuel
Araya, Monica
Rodriguez, Warner
Volio, Andres
Zuniga, Carlos
Valladares, Rene
Villalobos, Manuel
Solis, Bruno
Guadamuz, Randall
Antillon, Sofia
Campos, Christian
Soto, Tatiana
Murillo, Adriana
Brenes, Alejandro
Rivera, Tania
Rodriguez, Luis
Baptista, Joao
Zeledon, Zenen
Ordonez, Pablo
Jimenez, Ernesto
Gonzalez, Ileana
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S185 - S186

← 1 2 3 4 5 →